Publications of U. Reichl
All genres
Talk (263)
581.
Talk
Affinity chromatography of cell culture derived Vaccinia Virus. Vaccine Technology II, Albufeira, Algarve, Portugal (2008)
582.
Talk
Vero or MDCK cells for influenza A virus production in microcarrier systems? European BioPerspectives 2007, Cologne, Germany (2007)
583.
Talk
Implementation of analytical methods during upstream processing for an influenza A virus production process. Vaccine Production : Analytical Methods, Characterisation, Scale-up and Manufacturing, Cologne, Germany (2007)
584.
Talk
Lectin-affinity chromatography: a novel purification method for cell culture based Influenza vaccine production from the current season 2006/07. European BioPerspectives 2007, Cologne, Germany (2007)
585.
Talk
Lektin-Affinitätschromatographie - Neuartige Methode zur Aufreinigung humaner Influenza Viren aus Zellkulturen zur Impfstoffproduktion. DECHEMA/GVC Vortrag- und Diskussionstagung "Aufarbeitung biotechnologischer Produkte", Osnabrück, Germany (2007)
586.
Talk
Efficient influenza virus capture from cell cultivation broth by a novel affinity chromatography. AIChE Annual meeting 2007, Salt Lake City, USA (2007)
587.
Talk
Novel capturing method for currently spread influenza viruses from cell cultures by affinity separation. ISPPP 2007, Orlando, USA (2007)
588.
Talk
Characterisation of Glycosylation Patterns Utilizing a DNA-Sequenzer and Mass Spectrometry. 14th European Carbohydrate Symposium, Lübeck, Germany (2007)
589.
Talk
Characterisation of Glycosylation Patterns Utilizing a DNA-Sequenzer and a MALDI-TOF Mass Spectrometer. 7th Carbohydrate Bioengineering Meeting (CBM7), Braunschweig, Germany (2007)
590.
Talk
Elucidation of the Influenza A Virus Glycosylation Patterns with Respect to Vaccine Production Down to the Lower Zeptomolar Range. 21st International Symposium on MicroScale Bioseparations (MSB), Vancouver, BC, Canada (2007)
591.
Talk
Quantitative proteomic analysis of influenza A virus infected mammalian cells: Elucidation of virus / host cell interactions with respect to the vaccine production process. 27th International Symposium & Exhibit on the Separation of Proteins, Peptides & Polynucleotides (ISPPP 2007), Orlando, USA (2007)
592.
Talk
A Systems Perspective of Virus Replication in Mammalian Cell Cultures. Meeting at MPI Golm, Potsdam-Golm, Germany (2007)
593.
Talk
Influenza Vaccines: Challenges in Optimization of Virus Yields in Mammalian Cell Culture. Vaccine Congress, Amsterdam, The Netherlands (2007)
594.
Talk
Characterization of Cell Growth and Influenza Virus Replication in Microcarrier Culture. Kooperationsgespräch bei ROCHE AG, Penzberg, Germany (2007)
595.
Talk
A Systems Perspective of Influenza Virus Replication in Cell Cultures. European Conference on Complex Systems, Dresden, Germany (2007)
596.
Talk
Theoretical and Experimental Characterization of Influenza Virus Replication in Cell Cultures. Meeting Helmholtz-Zentrum, Braunschweig, Germany (2007)
597.
Talk
Theoretical and Experimental Characterization of Influenza Virus Replication in Cell Cultures. DECHEMA-Arbeitsausschuss Biotechnologie, Frankfurt/M., Germany (2007)
598.
Talk
Mathematical Modeling of Mammalian Cell Cultures - Cell Growth and Product Synthesis. MPG-CNRS Treffen, Paris, France (2007)
599.
Talk
MDCK cell derived influenza vaccines - aspects of up- and downstream processing. Meeting Merck & Co., Inc., USA (2007)
600.
Talk
Mathematical Modeling of Mammalian Cell Cultures: From Cell Populations to Individual Cells. Workshop "Systems biology", Leipzig, Germany (2007)